PUBLIC CONTRACT · 2021
Medicamentos do Grupo do 4
- Contract value
- €143,989.55
- Signed on
- 28 January 2021
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 10805585PUBLISHED DESCRIPTION
41/34/2021
Parties involved
- Awardee
- OM PHARMA, S.A.; Amgen Biofarmacêutica, Lda; Bayer Portugal, Lda; Novartis Farma - Produtos Farmacêuticos, S.A.
- Place of performance
- Portugal, Faro, Faro
- NUTS region
- PT150 - Algarve
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- OM PHARMA, S.A. · Tax ID 500207410
- Awardee
- Amgen Biofarmacêutica, Lda · Tax ID 502942959
- Awardee
- Bayer Portugal, Lda · Tax ID 500043256
- Awardee
- Novartis Farma - Produtos Farmacêuticos, S.A. · Tax ID 500063524
Values and timeline
- Contract price
- €143,989.55
- Procedure base price
- €0.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 5 July 2024
- Award date
- 28 January 2021
- Signing date
- 28 January 2021
- Performance period
- 62 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Melhor relação qualidade – preço
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- CP 2020/18 - Medicamentos do grupo 4: sangue
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 5005733
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.